BR9608837A - "composition obtained from cells to detect an infection by human immunodeficiency virus, apparatus, kit and methods for its detection, purification of protein and obtaining and treating human beings" - Google Patents

"composition obtained from cells to detect an infection by human immunodeficiency virus, apparatus, kit and methods for its detection, purification of protein and obtaining and treating human beings"

Info

Publication number
BR9608837A
BR9608837A BR9608837-0A BR9608837A BR9608837A BR 9608837 A BR9608837 A BR 9608837A BR 9608837 A BR9608837 A BR 9608837A BR 9608837 A BR9608837 A BR 9608837A
Authority
BR
Brazil
Prior art keywords
cells
immunodeficiency virus
methods
infection
kit
Prior art date
Application number
BR9608837-0A
Other languages
Portuguese (pt)
Inventor
Harry P Zhabilov
Original Assignee
Tomson U S A Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tomson U S A Ltd filed Critical Tomson U S A Ltd
Publication of BR9608837A publication Critical patent/BR9608837A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)

Abstract

<B>"COMPOSIçãO OBTIDA DE CéLULAS PARA DETECTAR UMA INFECçãO POR VìRUS DA IMUNODEFICIêNCIA HUMANA, APARELHO, KIT E MéTODOS PARA SUA DETECçãO, PURIFICAçãO DA PROTEìNA E SUA OBTENçãO E TRATAMENTO DO SER HUMANO"<D>. Esta invenção refere-se à área de imunologia e virologia; e especificamente refere-se a composições obtidas de células de timo de mamíferos as quais são úteis como diagnósticos, vacinas e terapêuticos para infecções por vírus da imunodeficiência humana (HIV) e doenças relacionadas, tais como síndrome da imunodeficiência adquirida (AIDS) e complexo relacionado à AIDS (ARC), o diagnóstico, a vacina e métodos terapêuticos, bem como aparelhos utilizando estas composições, são também revelados.<B> "COMPOSITION OBTAINED FROM CELLS TO DETECT AN INFECTION BY HUMAN IMMUNODEFICIENCY VIRUS, APPARATUS, KIT AND METHODS FOR THEIR DETECTION, PROTEIN PURIFICATION AND THEIR OBTAINING AND TREATMENT OF THE HUMAN BEING" <D>. This invention relates to the field of immunology and virology; and specifically refers to compositions obtained from mammalian thymus cells which are useful as diagnostics, vaccines and therapeutics for human immunodeficiency virus (HIV) infections and related diseases, such as acquired immunodeficiency syndrome (AIDS) and related complex AIDS (ARC), diagnosis, vaccine and therapeutic methods, as well as devices using these compositions, are also revealed.

BR9608837-0A 1995-05-01 1996-05-01 "composition obtained from cells to detect an infection by human immunodeficiency virus, apparatus, kit and methods for its detection, purification of protein and obtaining and treating human beings" BR9608837A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43188395A 1995-05-01 1995-05-01
US48554895A 1995-06-07 1995-06-07
PCT/US1996/006079 WO1996034886A1 (en) 1995-05-01 1996-05-01 Compositions and methods for detecting and treating acquired immunodeficiency syndrome

Publications (1)

Publication Number Publication Date
BR9608837A true BR9608837A (en) 1999-12-07

Family

ID=27029254

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9608837-0A BR9608837A (en) 1995-05-01 1996-05-01 "composition obtained from cells to detect an infection by human immunodeficiency virus, apparatus, kit and methods for its detection, purification of protein and obtaining and treating human beings"

Country Status (6)

Country Link
JP (1) JP3816524B2 (en)
AR (1) AR001840A1 (en)
AU (1) AU721463B2 (en)
BR (1) BR9608837A (en)
NZ (1) NZ308708A (en)
WO (1) WO1996034886A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2215108A4 (en) 2007-10-23 2012-07-04 Univ Colorado Competitive inhibitors of invariant chain expression and/or ectopic clip binding
AU2009274568A1 (en) * 2008-07-25 2010-01-28 The Regents Of The University Of Colorado Proteins for use in diagnosing and treating infection and disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4415553A (en) * 1973-08-06 1983-11-15 Dso "Pharmachim" Compositions, processes for their preparation and method for treatment of neoplasms
WO1985003003A1 (en) * 1984-01-12 1985-07-18 Volker Rusch Biologically active substance with hormonal properties, production process thereof and utilization of histones for medical purposes
WO1989005455A1 (en) * 1987-12-02 1989-06-15 The Regents Of The University Of California Aids-related anti-t-cell antibody test
GB9209874D0 (en) * 1992-05-07 1992-06-24 Ml Lab Plc Pharmaceutical compositions

Also Published As

Publication number Publication date
AU721463B2 (en) 2000-07-06
NZ308708A (en) 1998-11-25
AR001840A1 (en) 1997-12-10
JP3816524B2 (en) 2006-08-30
AU5851996A (en) 1996-11-21
WO1996034886A1 (en) 1996-11-07
JP2002504885A (en) 2002-02-12

Similar Documents

Publication Publication Date Title
CY1106207T1 (en) ANTIINIC NUCLEOSITE DERIVATIVES
CY1108578T1 (en) PHARMACEUTICAL COMPOSITIONS (KITS) INCLUDING DIHYDROPYRIDINONES COMPOUNDS AND AN IMMUNE REGULATORY (OR ANTI-FLUID INFECTION)
BR9708114A (en) Xanthone analogues for the treatment of infectious diseases.
EA199901031A1 (en) Derivatives of benzimidazole
TR199802537T2 (en) Peptide tèrevleri.
EA200100302A1 (en) METHODS AND COMPOSITIONS FOR PROTECTIVE AND THERAPEUTIC GENETIC IMMUNIZATION
BR0012919A (en) Vaccine for use in the prophylaxis and / or treatment of white spot syndrome in crustaceans, structural protein derived from white point syndrome virus, nucleic acid sequence, use of a structural protein, pharmaceutical composition, antibodies, vaccine or pharmaceutical formulation, and, diagnostic kit for wssv detection
NO971625L (en) Novel peptides with immunomodulatory effects
TR199801614T2 (en) Peptide derivatives
AR003941A1 (en) HIV-1 NEUTRALIZING HUMAN MONOCLONAL ANTIBODIES
BR9608837A (en) &#34;composition obtained from cells to detect an infection by human immunodeficiency virus, apparatus, kit and methods for its detection, purification of protein and obtaining and treating human beings&#34;
BR9707142A (en) Purified polynucleotide, dna, vector, host cell, hybridoma cell line, monoclonal antibody, processes to produce exodus, to increase resistance to infection by human immunodeficiency virus (hiv), for treatment of human immunodeficiency virus (hiv) infection , for the protection of bone marrow progenitor cells against cytotoxic effects and for the treatment of myeloproliferative diseases, and the use of an exodus protein product.
ES2057579T3 (en) PEPTIDES E1 AND C OF RUBEOLA.
EA200500533A1 (en) PEPTIDE DERIVATIVES - MERCURY INHIBITORS IN HIV INFECTION
NO980300L (en) New high molecular weight human MP52 proteins
DE69615015D1 (en) COMPOSITIONS AND METHODS FOR DETECTING AND TREATING THE ACQUIRED IMMUNE DEFICIENCY SYNDROME
BR0209892A (en) Method of preparing a compound, compound, pharmaceutical composition, use of a compound, and method of treating a patient suffering from an hppar alpha mediated disease or condition
DE69726743D1 (en) PEPTID ANALOGS CONTAINING A SEVEN LACTAMRING
ES2152285T3 (en) PHARMACEUTICAL PREPARATION BASED ON THE CLARA CC10 CELL PROTEIN AND ITS USE AS A MEDICINAL PRODUCT AND IN DIAGNOSIS.
FR2694938B1 (en) NOVEL PEPTIDES, ANTIBODIES DIRECTED AGAINST SUCH PEPTIDES, ANTI-IDIOTYPIC ANTIBODIES, APPLICATION AS DRUGS, PHARMACEUTICAL COMPOSITIONS AND DIAGNOSTIC KITS CONTAINING THEM.
ATE183652T1 (en) SYNTHETIC PEPTIDES FOR THE TREATMENT OF MYASTHENIA GRAVIS
UA42693C2 (en) The medicine for treating the infection by lentivirus, the preparation for human treatment which is infected by lentivirus.
SE8206128D0 (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF NURSTONES Caused By Infection
BRPI0417798A (en) 72 kda outer membrane protein of brachyspira pilosicoli and its diagnostic and therapeutic uses
EP0491888A4 (en) Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B24C Patent annual fee: request for for restoration

Free format text: REFERENTE A 13A,14A E 15A ANUIDADE(S).

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE AO DESPACHO 24.3 NA RPI 2113 DE 05/07/2011, E COMPROVAR O RECOLHIMENTO DA 12A,16A E 17A ANUIDADE.